We are live on ! Find out more
SCM

Silverarc Capital Management Portfolio holdings

AUM $849M
1-Year Est. Return 470.8%
This Fund
S&P 500
This Quarter Est. Return
+7.72%
1 Year Est. Return
+470.8%
3 Year Est. Return
+3,352.06%
5 Year Est. Return
+7,957.7%
10 Year Est. Return
–
AUM
$223M
AUM Growth
+$50.6M
Cap. Flow
+$48.7M
Cap. Flow %
21.84%
Top 10 Hldgs %
40.82%
Holding
94
New
12
Increased
43
Reduced
11
Closed
23

Top Buys

1
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$6.72M
2
APEN
Apollo Endosurgery, Inc.
APEN
+$6.46M
3
IMGN
Immunogen Inc
IMGN
+$5.37M
4
BLU
BELLUS Health Inc.
BLU
+$4.88M
5
BBIO icon
BridgeBio Pharma
BBIO
+$4.23M

Top Sells

1
FULC icon
Fulcrum Therapeutics
FULC
+$5.24M
2
NXTC icon
NextCure
NXTC
+$3.68M
3
ARVN icon
Arvinas
ARVN
+$3.06M
4
INSM icon
Insmed
INSM
+$2.11M
5
ERAS icon
Erasca
ERAS
+$1.98M

Sector Composition

1 Healthcare 93.29%
2 Financials 5.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMGN
1
DELISTED
Immunogen Inc
IMGN
$11.2M 5.04%
1,514,411
+864,492
+133% +$5.37M
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$11.1M 4.96%
80,348
+18,451
+30% +$2.35M
ITCI
3
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$10.2M 4.57%
195,000
+93,110
+91% +$3.91M
MRUS
4
DELISTED
Merus
MRUS
$10.2M 4.56%
320,174
-25,790
-7% -$729K
VCYT icon
5
Veracyte
VCYT
$4.67B
$9.12M 4.09%
221,362
+41,814
+23% +$1.85M
MRTX
6
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$8.91M 3.99%
60,757
+14,816
+32% +$2.3M
BLU
7
DELISTED
BELLUS Health Inc.
BLU
$8.86M 3.97%
1,100,000
+735,000
+201% +$4.88M
COGT icon
8
Cogent Biosciences
COGT
$6.57B
$7.3M 3.27%
850,935
+173,035
+26% +$1.5M
LKFT
9
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
$7.11M 3.18%
+128,901
New +$6.72M
CERS icon
10
Cerus
CERS
$625M
$7.1M 3.18%
1,042,722
+423,353
+68% +$2.85M
HZNP
11
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$6.65M 2.98%
61,700
+9,231
+18% +$1.01M
ITOS
12
DELISTED
iTeos Therapeutics
ITOS
$6.43M 2.88%
138,006
+21,075
+18% +$702K
APEN
13
DELISTED
Apollo Endosurgery, Inc.
APEN
$6.24M 2.79%
+739,604
New +$6.46M
RACB
14
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$5.42M 2.43%
556,890
+83,494
+18% +$821K
IMTX icon
15
Immatics
IMTX
$1.3B
$5.26M 2.36%
391,155
-46,711
-11% -$584K
LHDX
16
DELISTED
Lucira Health, Inc. Common Stock
LHDX
$4.43M 1.99%
515,000
+294,242
+133% +$1.87M
SRRA
17
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$4.17M 1.87%
192,045
+28,559
+17% +$629K
ACRS icon
18
Aclaris Therapeutics
ACRS
$756M
$4.16M 1.87%
286,226
+112,899
+65% +$1.71M
AMYT
19
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$3.78M 1.69%
350,213
-166,008
-32% -$1.79M
CTIC
20
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$3.68M 1.65%
+1,483,829
New +$3.63M
CYPH
21
Cypherpunk Technologies Inc
CYPH
$82M
$3.28M 1.47%
101,366
+39,366
+63% +$1.09M
KRYS icon
22
Krystal Biotech
KRYS
$9.78B
$3.27M 1.46%
+46,670
New +$2.72M
MORF
23
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$3.19M 1.43%
67,440
+9,736
+17% +$522K
CRNX icon
24
Crinetics Pharmaceuticals
CRNX
$8.88B
$3.18M 1.42%
111,860
+62,478
+127% +$1.54M
UTHR icon
25
United Therapeutics
UTHR
$22.2B
$3.14M 1.41%
14,551
-6,638
-31% -$1.3M
1
2 3 4

Similar funds

BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
EFG
Embree Financial Group Chicago, Illinois $849M AUM 19.63% 1-Year Est. Return
LA
Legacy Advisors Plymouth Meeting, Pennsylvania $848M AUM 21.32% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
CFP
Catalyst Financial Partners Boston, Massachusetts $847M AUM 29.19% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $846M AUM 32.1% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $852M AUM 0.1% 1-Year Est. Return